or Try an Advanced Search...

    Technical Analysis for DNLI - Denali Therapeutics Inc.

    Grade Last Price % Change Price Change
    B 22.01 -5.21% -1.21
    DNLI closed down 5.21 percent on Monday, July 1, 2024, on approximately normal volume.
    3 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent Up Up Flat
    Historical DNLI trend table...
    Date Alert Name Type % Chg
    Non-ADX 1,2,3,4 Bullish Bullish Swing Setup -5.21%
    Pocket Pivot Bullish Swing Setup -5.21%
    Volume Surge Other -5.21%
    Inside Day Range Contraction -5.21%
    Outside Day Range Expansion -4.18%
    NR7 Range Contraction 0.05%
    Slingshot Bullish Bullish Swing Setup -1.70%
    Shooting Star Candlestick Bearish -3.93%
    Lizard Bearish Bearish Day Trade Setup -3.93%
    Stochastic Reached Overbought Strength -3.93%
    Older End-of-Day Signals for DNLI ...

       Recent Intraday Alerts

    Alert Time
    10 DMA Support about 6 hours ago
    Fell Below Previous Day's Low about 8 hours ago
    Down 5% about 8 hours ago
    Fell Below 10 DMA about 8 hours ago
    Down 1 ATR about 8 hours ago
    View Earlier Intraday Alerts

    Get a Trading Sidekick!

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Read My Charts!
    Configure default chart indicators
    DNLI Chart by TradingView
    Basic chart:

    Profile

    Denali Therapeutics Inc is a clinical-stage biopharmaceutical company. The company is engaged in developing therapeutics for neurodegenerative diseases, including Alzheimer's disease, Parkinson's disease and amyotrophic lateral sclerosis.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Biopharmaceutical Organ Systems Neuroscience Alzheimer's Disease Parkinson's Disease Neurological Disorders Neurodegenerative Diseases Amyotrophic Lateral Sclerosis Degenerative Disease Neurodegeneration Senescence

    Is DNLI a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 3 bullish, 0 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Jun 28 Denali (DNLI) Outperforms Industry in 3 Months: Here's Why
    Jun 24 Denali Therapeutics (DNLI) Moves 5.8% Higher: Will This Strength Last?
    Jun 15 ALS therapy market seen increasing to nearly $1.3B by 2029
    Jun 7 Why Is Prothena (PRTA) Down 1.5% Since Last Earnings Report?
    Jun 7 Companies Like Denali Therapeutics (NASDAQ:DNLI) Are In A Position To Invest In Growth
    Jun 6 Denali: Cash, Big Pharma Partnerships And High Potential For MPS-II Do Not Warrant A Buy
    Jun 6 Why Is Denali Therapeutics (DNLI) Up 15.6% Since Last Earnings Report?
    Jun 4 Denali's (DNLI) Candidate Selected for FDA's START Pilot Program
    Jun 3 Denali Therapeutics Announces FDA Has Selected DNL126 (ETV:SGSH) for MPS IIIA (Sanfilippo Syndrome Type A) for START Pilot Program Intended to Accelerate Development of Rare Disease Therapies
    May 13 Denali Therapeutics: MPS Treatment Program Continues With End Of 2024 Data
    See more DNLI news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 30.79
    52 Week Low 14.56
    Average Volume 1,275,919
    200-Day Moving Average 19.46
    50-Day Moving Average 19.42
    20-Day Moving Average 21.63
    10-Day Moving Average 22.06
    Average True Range 1.17
    RSI (14) 55.36
    ADX 24.18
    +DI 30.58
    -DI 17.99
    Chandelier Exit (Long, 3 ATRs) 20.36
    Chandelier Exit (Short, 3 ATRs) 21.50
    Upper Bollinger Bands 23.36
    Lower Bollinger Band 19.90
    Percent B (%b) 0.61
    BandWidth 16.03
    MACD Line 0.83
    MACD Signal Line 0.80
    MACD Histogram 0.0291
    Fundamentals Value
    Market Cap 3.04 Billion
    Num Shares 138 Million
    EPS -0.94
    Price-to-Earnings (P/E) Ratio -23.41
    Price-to-Sales 7.32
    Price-to-Book 2.23
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 23.97
    Resistance 3 (R3) 24.13 23.62 23.65
    Resistance 2 (R2) 23.62 23.12 23.55 23.54
    Resistance 1 (R1) 22.82 22.81 22.57 22.66 23.43
    Pivot Point 22.31 22.31 22.19 22.24 22.31
    Support 1 (S1) 21.51 21.81 21.26 21.36 20.59
    Support 2 (S2) 21.00 21.50 20.93 20.48
    Support 3 (S3) 20.20 21.00 20.37
    Support 4 (S4) 20.05